| Authors: |
Struble EB; Division of Plasma Protein Therapeutics, Office of Tissues and Advanced Therapies, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA., Murata H; Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA., Komatsu T; Division of Antivirals, Office for New Drugs, Center for Drugs Evaluation and Research, United States Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA., Scott D; Division of Plasma Protein Therapeutics, Office of Tissues and Advanced Therapies, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA. |
